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we undertook the characterization of an uptake system for carnitine in adult rat heart myocytes. The procedure that we used to prepare myocytes for this study yielded cells that did not undergo the rapid loss of membrane integrity as measured by trypan blue exclusion in the presence of physiological concentrations of calcium which characterized previous myocyte preparations. This provides an improved model of active cardiac myocytes (Frangakis et al., 1980) . Carnitine (y-trimethyl-/?-hydroxybutyrobetaine) is a naturally occurring compound found in high concentration in skeletal and cardiac muscle (Pearson and Tubbs, 1967) . Carnitine's role in the transfer of activated long-chain fatty acid esters of coenzyme A across the mitochondrial membrane is well known, but, in addition, a new role for carnitine has emerged from work on cardiac performance in the ischemic state. Recent studies have demonstrated beneficial effects of exogeneous carnitine on animal and human cardiac functions: a vasodilating and inotropic effect in the dog (Brooks et al., 1977) , protection of the myocardium from ischemic changes in the dog (Vick et al., 1976) (Folts et al., 1978) , reduction of arrhythmias in the cat (DiPalma et al., 1975) , protection against additional compromise of mechanical performance in ischemic swine heart caused by excess free fatty acids (FFA) (Liedtke et al., 1979) , and an improved stress tolerance of the ischemic myocardium in humans (Thomsen et al., 1977) .
Carnitine's role in the metabolism of fatty acids with a reduction in intracellular levels of long-chain fatty acid esters of coenzyme A has been suggested to be related to its beneficial effects. Myocardial ischemia has been shown to be associated with reduced levels of carnitine palmityltransferase activity (Wood et al., 1979) and free carnitine (Feuvray et al., 1979) , increased levels of carnitine esters, and a concomitant increase in the concentration of long-chain fatty acid esters of coenzyme A (Shug et al., 1975a) . These acyl-CoA esters, in turn, are known to inhibit the adenine nucleotide translocase, the transport protein for ADP and ATP across the mitochondrial membrane (Shrago 1978) . This translocase plays an essential role in the transfer of energy from oxidative phosphorylation to extramitochondrial processes. Exogenous carnitine can reverse in vitro inhibition of adenine nucleotide translocase caused by long-chain acyl-CoA esters and restore mitochondrial function (Shug et al., 1975b) . Finally, exogenous carnitine has been shown to reverse in vivo inhibition of adenine nucleotide translocase caused by ischemia after coronary artery occlusion in the dog and to decrease epicardial ST segment depressions (Folts et al., 1978) .
Carnitine is synthesized in the rat from lysine and methionine (Cox and Hoppel, 1973) . Many tissues are able to synthesize intermediates in carnitine biosynthesis, but the last step, the hydroxylation of y-trimethyl-butyrobetaine, occurs primarily in the liver, and not in the heart or skeletal muscle (Cox and Hoppel, 1974) . Thus, tissues such as heart and skeletal muscle that depend on carnitine for fatty acid oxidation must rely on transport of the compound from the plasma and not endogenous synthesis. The concentration of carnitine in the rat heart is about 60 times greater than that found in the plasma (Marquis and Fritz, 1965 ), suggesting that exogenous carnitine must be transported against a concentration gradient.
Work on carnitine transport in the isolated liver cell (Christiansen and Bremer, 1976) , the cultured human heart cell (Bohmer et al., 1977) , and rat limb muscle (Rebouche, 1977) has demonstrated that uptake of radiolabeled carnitine occurs against a concentration gradient, is energy dependent, and is inhibited by structural analogs of carnitine. In addition, all of these studies have shown carnitine uptake to be a saturable process, but the reported kinetic constants have varied widely: liver cells had a K m of 5.6 mti and a V ma x of 2.4 nmol/mg protein per minute, cultured heart cells had a K m of 4.8 JIM and a V max of 8.7 pmol/jug DNA per hour, and rat limb muscle had a K m of 60 JIIM and a V max of 22 nmol/g tissue per hour.
Our earlier report of energy dependent carnitine transport in myocytes employed myocytes that rapidly lost membrane integrity (trypan blue exclusion) and rapidly became maximally contracted when exposed to physiological concentrations of calcium. With the development of cardiac myocytes able to tolerate physiological concentrations of calcium, we have been able to characterize a transport system for carnitine that: (1) unlike the previous model demonstrates a high affinity transport system which conforms to Michaelis-Menten kinetics, (2) is appreciably inhibited by appropriate structural analogs, (3) has been characterized as to the effects of various ions, hormones, and cardioactive drugs. Finally 7,8-diOH CPZ, a metabolite of chlorpromazine, has been shown to inhibit efflux of carnitine from myocytes which displayed a high degree of permeability to compounds of low molecular weight.
Methods
Adult rat heart myocytes able to tolerate physiological concentrations of calcium without rapidly losing membrane integrity and contracting into a condition of rigor were isolated according to the procedure of Frangakis et al. (1980) . Hearts from adult Sprague Dawley rats (250-300 g) were perfused with Joklik MEM buffer (GIBCO) containing collagenase and hyaluronidase. Isolated cells were allowed to settle in buffer at room temperature while broken cells and non-muscle cells remained dispersed and, thus, were removed by aspiration. Approximately 80-95% of freshly prepared cells exclude the dye trypan blue and 60-75% of the cells excluded the dye after 90 minutes at 37° in the presence of 2 mM calcium. Glycolysis, fatty acid oxidation, and the tricarboxylic acid cycle remain intact as myocytes metabolize glucose, palmitate, and pyruvate linearly for more than 2 hours. My- VOL. 48, No. 3, MARCH 1981 ocytes not able to tolerate a physiological calcium concentration were prepared by the method of Grosso et al. (1977) .
Uptake of radiolabeled carnitine was measured using 3 H-methyl-D,L-carnitine from Amersham (1.7 Ci/mmol) and after thin layer chromatography [butanol:water:acetic acid (120:50:30)] indicated the solution was 98% homogenous and was used without subsequent purification. 14 C-Sorbitol was used as a marker of extracellular space. Addition of L-(-)carnitine (Otsuka Pharmaceutical Factory) was made to provide the carnitine concentration used for a given experiment. In a typical experiment, 2 /xCi/ml 3 H-D,L-carnitine and 0.2 /uCi/ml 14 C-sorbitol would be added to 1 ml of cells (1 mg cellular protein, approximately). The total 3 H-carnitine measured in each aliquot of cells was corrected to yield the net 3 H-carnitine transported into the cell. Cell water was measured using 3 H2O and similarly corrected with 14 C-sorbitol. Isolated myocytes, 1 mg protein in 1.0 ml medium, were added to a plastic centrifuge tube containing labeled compounds to start the uptake process. Calcium was not added to the approximate 10 JUM calcium innately contained in the incubation buffer, except as specified for a given experiment. Cells pipetted on to a 1:1 mixture of dibutyl and dioctyl phthalate esters were pelleted by centrifugation. Cells were counted after base (NaOH) hydrolysis of the pellet and subsequent neutralization (HC1). Actual dpm of 3 H and 14 C were calculated using standard double-label counting techniques (Kobayashi and Maudsley, 1974) .
In those experiments where cells were filtered and rinsed rather than pelleted by centrifugation, addition of 3 ml of 1 mM unlabeled carnitine at 4°C was made to stop transport. Cells were then filtered on Nuclepore filters (10/^m pore size, Nuclepore Corp.). The niters were rinsed with one additional 3-ml aliquot of 1 mM carnitine at 4°C and radioactivity on the filters measured.
L-Carnitine was measured by the method of Parvin and Pande (1977) . This method measures picomole amounts of carnitine and is based on the enzymatic conversion of carnitine plus radiolabeled acetyl-CoA to radiolabeled acetylcarnitine in the presence of carnitine acetyltransferase. Protein was measured using the method of Lowry et al. (1951) .
Because of the day-to-day variation in myocytes, the amount of 3 H-carnitine transported into myocytes varied widely (5.8 to 20.5 pmol/mg protein). Values obtained on a given day were converted to percent of the matched control group mean prior to being combined with values obtained on different days. Computation of statistical significance of experimental treatment was made using the twotailed Student's t-test for paired samples. 
Results

Carnitine Uptake
Total carnitine (free and carnitine esters) per mg protein was measured at the start of the perfusion with hyaluronidase and collagenase and in isolated myocytes. The isolation procedure resulted in a 69% decrease in heart myocyte carnitine concentration. Estimation of intracellular fluid volume was made by subtracting 14 C-sorbitol space from total 3 H water space found in the pellets. Using an average value for non-sorbitol space of approximately 3 jul/ mg protein, an intracellular concentration of carnitine in the myocytes was calculated to be between 530 and 730 JUM. Normal plasma carnitine concentration in the rat has been found to be approximately 40 /xM (Marquis and Fritz, 1965, and Rebouche, 1977) .
Carnitine accumulation into the non-sorbitol space was found to be biphasic, as shown in Figure  1 . The initial rapid phase of carnitine uptake was not inhibited by the addition of 2,4-dinitrophenol (DNP). Iodoacetate, often used to block glycolysis, caused damage to the cell membrane making 14 Csorbitol space equivalent to 3 H 2 O space. We were therefore unable to establish if the initial phase of 3 H-carnitine accumulation was dependent on energy production from glycolysis or not. The subsequent phase of carnitine accumulation was in- hibited strongly by DNP and represents the energydependent uptake of carnitine.
The effects of different ions at various concentrations on carnitine uptake were studied and the results are shown in Table 1 . Uptake was not altered by substitution of LiCl for NaCl. Addition of calcium to a final concentration of 1 mM decreased carnitine uptake to 51.8% of control. Addition of 1 mM magnesium did not alter uptake in cells from matched controls.
Effect of Carnitine Concentration
Uptake of carnitine was measured with respect to increasing concentrations of carnitine in the incubating medium, and the results are shown in Figure 2 . The transport system is composed of a high affinity saturable system which follows Michaelis-Menten kinetics and a low affinity component which does not. The low affinity system has been described previously by us and was the only system demonstrable in the preparation of myocytes that did not tolerate physiological concentrations of calcium. Using the mathematical correction of Christensen (1975) to separate the high affinity system from the low affinity system which does not show saturation, the high affinity system's K m is calculated to be 60 JUM. This value is in the range of plasma carnitine concentrations. The system's V max was calculated to be 110 pmol/ mg protein per hour. The K m measured in the isolated rat myocyte is in good agreement with the K m measured by Rebouche (1977) in the rat limb muscle, but is a somewhat lower in affinity than the 4.8 ftM measured by Bohmer et al. (1977) in cultured human heart cells.
Effect of Structural Analogs on Uptake
The ability of structural analogs to inhibit carnitine uptake (total high affinity and low affinity uptake) is shown in Table 2 . As is the case for the carnitine transport system in rat liver, both D and L carnitine were equally effective at inhibiting uptake of 3 H-D,L-carnitine (reduced to 17% of control). The hydroxy group on carbon 3 which establishes the D or L chirality of carnitine is not present in the Control 100 ± 7.0 100 ± 3.8 100 ± 3.6 100 ± 1.9' 100 ± 1.9* 100 ± 1.6f 100 ± 3.0
The appropriate additions or substitution of ions were made for cells incubated for 1 hour with 10 /IM 3 H-D,L-carnitine. Individual data points were converted to percent of the mean value of the day's control before experiments from different days were combined. Values are mean ± SEM of n determinations.
• P < 0.01; t P < 0.001. 100 300 500 750 1000
Carnitine Concentration ^M Uptake of 10 / AM 'H-D.L-carnitine for 1 hour was measured in the presence and absence of the structural analogs (1 mM) listed above. Values expressed as percent of control are the mean ± SEM (n = 8).
• P < 0.02; f P < 0.01; t P < 0.001. metabolic precursor deoxycarnitine (y-trimethylbutyrobetaine). Inhibition of uptake with deoxycarnitine was to 32% of control and to 27% of control with acetylcarnitine. Choline and y-aminobutyric acid, which decreased carnitine uptake, were less effective as inhibitors. The rate of carnitine efflux from cells prelabeled with 3 H-carnitine was not significantly increased by the presence of 40 JIM unlabeled carnitine or acetylcarnitine nor with 1 mM carnitine or acetylcarnitine, an amount far in excess of plasma levels (data not shown).
Effect of Pharmacological Agents on Uptake
A variety of pharmacological agents were screened for effects on carnitine uptake. As shown in Table 3 , significant decreases in carnitine uptake were observed after exposure to dibutyrl cyclic AMP, the /S-adrenergic agonist isoproterenol, and the antagonist propranolol. The 7V,iV-dimethyl analog of propranolol which does not interact with the /J-receptor as agonist or antagonist and is devoid of local anesthetic properties (Schuster et al., 1973) reduced transport to 87% of control, but failed to attain statistical significance (P > 0.05). The local Effects of pharmacological agents on 'H-camitine uptake. Myocyte uptake of 50 pM 'H-carnitine was measured after 1 hour at 37°C in the presence of various agents at 10"" M. Values expressed as mean ± SEM of control uptake. Ouabain studies were at the concentration, with or without calcium, as indicated by the table.
* P < 0.05; t P < 0.02; § P < 0.01; %P< 0.001.
anesthetics, lidocaine and tetracaine, however, were equally effective in decreasing camitine transport. Ouabain decreased transport of camitine at concentrations above 10~6 M in myocytes with no added calcium, but only at 10~4 M if 1 mM calcium was present. No significant alteration in camitine transport was observed in myocytes treated with verapamil, which acts at the external surface of the cell to block slow-channel ion movement such as calcium (Shigenobu et al., 1974) , nor was any effect observed with chlorpromazine. Similarly, no significant alteration of camitine transport was observed with thioridizine, haloperidol, stelazine, doxepine, imipramine, chlorimipramine, atropine, or carbachol (data not shown).
In our earlier studies of camitine transport, we reported that the auto-oxidation product of 7,8-diOH CPZ produced an energy dependent 2-to 4-fold increase in camitine accumulation. This increase was correlated with the magnitude of the absorbance peak at 510 nm from the product of auto-oxidation of 7,8-diOH CPZ, and only structural analogs readily undergoing auto-oxidation to a phenothiazine ortho-quinone were found capable of effecting this increase in heart myocyte 3 H-D,L-carnitine accumulation. Maximal differences were observed after 10-15 minutes of phenothiazine exposure and increasing concentrations of calcium progressively diminished the magnitude of the effect. The data in Table 4 show that when myocytes treated with 7,8-diOH CPZ were filtered our previous (more permeable) heart cell preparations and our current cell preparations showed quantitative differences in camitine accumulation. The more permeable cells with 7,8-diOH CPZ showed 3.5 times the accumulation of 3 H-carnitine than did the matched controls, whereas the current preparation of myocytes had only 1.5 times the accumulation of 3 H-carnitine above the matched controls. When cells were centrifuged through a non-aqueous medium into a pellet, rather than being filtered and rinsed, no stimulation of camitine accumulation was observed. No aggregation of cells was observed in the presence or absence of 7,8-diOH CPZ. Similar values were observed with 7,8-dioxo CPZ, the quinone form of the dihydroxy compound (data not shown). To determine the specificity of the 7,8-diOH CPZ effect as measured by filtration method, 3 H-2-deoxyglucose (2-DG) and 3 H-a-aminoisobutyric acid (AIB) accumulation was measured. Myocytes incubated with 7,8-diOH CPZ for 10 minutes had greater radioactivity than control cells for both 2-DG (116% of control) and ABI (112% of control) ( Table 4 ). The stimulation proved to be a transient one, with incubations beyond 30 minutes not showing significant increases in accumulation of these compounds, nor did introduction of the drug to cells for a second exposure provide additional stimulation, suggesting that the cell system was capable of being stimulated only the one time (data not shown).
By preloading cells with 3 H-carnitine and using the centrifugation technique, it was possible to show that 7,8-diOH CPZ had an effect on efflux (Fig. 3) . Myocytes treated with 7,8-diOH CPZ after preloading with 3 H-carnitine displayed lower camitine efflux at the time points studied (P < 0.05). The efflux curve is biphasic with the initial phase of efflux being rapid and more sensitive to the presence of 7,8-diOH CPZ than the second, slower, phase of efflux. This suggested that 7,8-diOH CPZ might be decreasing permeability.
Because 2-DG, camitine, and sorbitol demonstrated nearly identical efflux curves during the initial rapid phase, it seems probable that the initial rapid phase represents efflux of label from cells which are highly permeable to labels of this sort, Cells were either filtered (F) or pelleted (P) as described in Methods. Incubations were with or without 10" 5 M 7,8-diOH CPZ for 10 minutes. "Previous cells" refers to myocytes not able to tolerate physiological calcium, prepared by the method of Grosso et al. (1977) . All other cells were prepared by the method of Frangakis et al. (1980) . Values are the mean ± SEM (n = 6). * P < 0.02; f P < 0.01; fP< 0.001. and the second phase results from efflux from more intact cells. Therefore, the percentage of highly permeable cells appears to have been decreased by 7,8-diOH CPZ. The possibility that the myocyte's permeability had been decreased was confirmed when trypan blue exclusion was measured in the presence and absence of 7,8-diOH CPZ. As shown in Figure 4 , less trypan blue was taken up by cells exposed to 7,8-diOH CPZ. More 3 H-carnitine remained in cells exposed to 7,8-diOH CPZ after being washed on filters, presumably because lowering the permeability resulted in a smaller quantity being washed out.
Discussion
Carnitine transport in the isolated adult rat heart myocyte required energy and occurred against a concentration gradient. Unlike the transport system of many amino acids, no requirement for sodium was observed. The uptake system had both high and low affinity components. The apparent K m of 60 JUM for the high affinity system is in the range of normal plasma carnitine. The low affinity system did not saturate at 1 mM carnitine and, at higher concentrations, did not display Michaelis-Menten saturability that would allow for reliable calculation of K m or V max ). The transport system possesses structural specificity but, like the liver, lacks stereospecificity (Christiansen and Bremmer, 1976) . The enzymes that are involved in ( 3PZ FIGURE 4 Effect of 7,8-diOH CPZ on carnitine uptake and trypan blue exclusions. A: Cells were incubated for 10 minutes with 10 pM 3 H carnitine in the presence and absence of 10~5 M 7,8-diOH CPZ. Cells then were filtered on Nuclepore membranes and washed with two 3-ml aliquots of buffer at 0°. Values are mean ± SEM (n = 5) and are statistically significant (P < 0.001). B: Cells were incubated for 15 minutes in the presence and absence of 10~b M 7,8-diOH CPZ. Trypan blue (0.05 ml of 1%) was added to each ml of sample, and after 3 minutes, the cells were pelleted and the buffer aspirated. Pellets were resuspended and sonicated in 1 ml H 2 O and the ODsso was measured in masked cuvettes. Values are mean ± SEM (n = 4) and are statistically significant (P < 0.01).
Minutes FIGURE 3 Carnitine efflux from myocytes. Myocytes were incubated with 10 \IM 3 H-carnitine for 1 hour at 37°C ( u C-sorbitol was not included). One half of the cell population was exposed to 7,8-diOH CPZ for 10 minutes (O) and both groups were centr:fuged at low speed. The fluid above the cells was aspirated before fresh buffer was used to resuspend the cells. At various times, cells were pelleted through a layer of dibutyl and dioctyl phthalate esters (1:1), and radioactivity in the pellet and supernatant was determined. Values expressed as percent of total radioactivity (mean ± SEM of quadruplicate samples). Values for treated (O) and untreated (9) were significantly different (P < 0.05) at all times past time carnitine transfer of fatty acids all are stereoselective for L-carnitine. Because only the L-isomer is produced in vivo, the lack of stereoselectivity by the transport system would not in any way limit its normal utility to the cell. Inclusion of acetylcarnitine or carnitine during 3 H-carnitine efflux from preloaded cells did not provide evidence for countertransport of carnitine out of the cell.
Regulation of the carnitine transport system appears complex, but sensitive to calcium. Addition of 1 mM calcium decreased carnitine uptake by 50%. Yet, manganese which enters the cell and often acts as a calcium congener, did not decrease uptake, nor did the blocker of the slow channel, verapamil. Ouabain decreased carnitine uptake significantly at concentrations above 10~6 M when no calcium was added to the incubation medium, but only at 10~4 M when 1 mM calcium was added.
The /?-adrenergic agonist, isoproterenol, and the antagonist, propranolol, decrease carnitine uptake by comparable amounts. The local anesthetics, lidocaine and tetracaine, were effective inhibitors of carnitine transport. The cholinergic agonist, carbachol, and the antagonist, atropine, failed to alter carnitine transport, as did a variety of tricyclic agents. These data suggest that control of carnitine transport in vivo may be sensitive to a variety of endogenous compounds and xenobiotics, although the regulatory controls are not yet discernible. VOL. 48, No. 3, MARCH 1981 In our initial studies , myocytes that could not tolerate physiological levels of calcium were exposed to 7,8-diOH CPZ, filtered, and rinsed with buffer. These cells contained 2 to 4 times more 3 H-carnitine than their matched controls. This effect was inhibited by 2,4-DNP and diminished by calcium. Myocytes that could tolerate physiological concentrations of calcium showed a similar, albeit lesser effect when measured by this method (Table 2) . No effect of 7,8-diOH CPZ on carnitine uptake by the same cells could be found when the centrifugation technique was used. Thus, 7,8-diOH CPZ was influencing net accumulation of carnitine as measured by filtration, but was not altering net uptake into cell space corrected for 3 Hcarnitine in the 14 C-sorbitol space of the pellet as measured by centrifugation. The disparity between filtration and centrifugation methods was repeated with 3 H-2-DG and 3 H-AIB and suggests that the effect is not substrate specific. Efflux studies suggested 7,8-diOH CPZ had changed the amount of carnitine lost from highly permeable cells. Less trypan blue entered cells after treatment with 7,8-diOH CPZ, suggesting a physical change had occurred in at least some of the cells which otherwise would have been found to be permeable to the dye.
The disparity between the filtration and centrifugation technique thus appears to result from different quantities being measured. The filtration technique measured material remaining after rinsing. An agent that helped to seal permeable cells would result in more carnitine remaining on the filter. The centrifugation technique measured only carnitine in nonsorbitol space. Because labeled sorbitol and carnitine would rapidly enter highly permeable cells in a constant ratio, subsequent changes in membrane permeability would not be detected with the centrifugation method. The large variation in the 7,8-diOH effect may relate not only to the extent of auto-oxidation of 7,8-diOH CPZ, but also the extent of membrane permeability. The cells which were not able to tolerate physiological calcium displayed greater membrane permeability than cells able to tolerate physiological calcium (Frangakis et al., 1980) and showed a greater 7,8-diOH CPZ effect on carnitine remaining on filters.
A possible explanation for the mechanism of 7,8-diOH CPZ action may be provided by the work of Elias and Boyer (1979) . They showed that certain hydroxylated chlorpromazine metabolites, including 7,8-diOH CPZ, possessed the ability to increase the extent of actin polymerized in vitro and suggested that the in vivo sol-gel state of a cell might be altered by this class of compounds. It is, therefore, suggested that cells which might otherwise leak their contents through limited openings in the membrane may, by proper arrangement and degrees of polymerization of internal and/or membrane structural components, be able to limit movement through these openings.
Increasing calcium concentration decreased the effect observed with 7,8-diOH CPZ . Chelation of calcium by 7,8-diOH CPZ decreases the autoxidation to the quinone 7,8-diOH CPZ (Rajan et al., 1974) and may reduce the availability of the active drug. Calcium is known to catalyze the depolymerization of many intracellular polymers (Lazarides, 1980) . It is interesting to note that low temperatures, which result in depolymerization of certain structural components in cells, had to be avoided in the preparation of myocytes that could tolerate physiological concentrations of calcium. The action of 7,8-diOH CPZ may provide a useful biochemical tool in studying how impaired cells maintain their integrity. The pharmacological utility of this agent may be limited by high levels of plasma calcium and by the relatively rapid autooxidation or clearance of the chlorpromazine metabolite. The 7,8-diOH metabolite of CPZ is unusually cardioactive (Akera et al., 1974) . This metabolite has been reported to produce a positive inotropic effect in isolated guinea pig hearts , causes release of catecholamines (Temma et al., 1977) , and inhibits Na + /K + -ATPase activity . Recently, administration of chlorpromazine was reported to prevent in vivo acceleration of phospholipid degradation and associated membrane dysfunction in ischemic myocardial cells (Chien et al., 1979) . This effect may, at least in part, be due to a metabolite of CPZ, but the mechanism which might unite this effect and the ones observed for 7,8-diOH CPZ remains to be studied.
We have characterized the carnitine transport system in isolated rat heart myocytes with the belief that this information would be of value in future work on the role of carnitine in myocardial ischemia and its treatment. The effect of 7,8-diOH CPZ also was investigated. The data suggest that, rather than specifically affecting carnitine transport, the cell membrane permeability decreases after treatment with 7,8-diOH CPZ. The potential of 7,8-diOH CPZ to decrease the efflux of carnitine that occurs during ischemia remains to be studied. This agent may also be useful in studying the ability of damaged cells to maintain homeostasis.
